Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1
Lukes, Julius, Winkowska, Lucie, Zwyrtkova, Martina, Starkova, Julia, Sramkova, Lucie, Stary, Jan, Trka, Jan, Zuna, Jan, Zaliova, MarketaVolume:
4
Journal:
HemaSphere
DOI:
10.1097/HS9.0000000000000489
Date:
December, 2020
File:
PDF, 677 KB
2020